Celiac Disease Eligible for CMDRP Research Funding for the First Time – Marilyn’s Message January 2023
2023 promises to be a year full of robust research, advocacy, and education efforts on behalf of our patient community.
Continue Reading2023 promises to be a year full of robust research, advocacy, and education efforts on behalf of our patient community.
Continue ReadingThe American College of Gastroenterology has updated its guidelines for the diagnosis and management of celiac disease, bringing current the recommendations outlined in 2013.
Continue ReadingConsider joining the CeDar Rose Study, a remote celiac disease study that will monitor individual gluten tolerance.
Continue ReadingThe Celiac Disease Foundation is pleased to announce it will provide patient recruitment and eligibility screening for Anokion’s phase 1b/2 clinical trial for KAN-101.
Continue ReadingOn October 13, 2022 the Celiac Disease Foundation hosted the Ask-the-FDA Educational Webinar with representatives from the U.S. Food and Drug Administration and Coeliac UK.
Continue ReadingThe Celiac Disease Foundation announces its newest appointee, William Thurston, to its Board of Directors.
Continue ReadingThe PROACTIVE Celiac Study is a phase 2 clinical trial testing the safety and effects of the investigational medication PRV-015.
Continue ReadingConsider joining the LILY Study, a phase 1 clinical trial for people with celiac disease investigating DONQ52, a new potential celiac disease treatment.
Continue ReadingiCureCeliac® is the Foundation’s patient-powered tool that is the single best resource for celiac disease researchers around the world helping to accelerate the search for treatments and a cure.
Continue ReadingWe are pleased to introduce a new 7-Day Mediterranean Diet Meal Plan, developed by Janelle Smith, Registered Dietitian at UCLA.
Continue Reading